Global Retirement Partners LLC Invests $720,000 in Encompass Health Corporation $EHC

Global Retirement Partners LLC purchased a new position in Encompass Health Corporation (NYSE:EHC) in the second quarter, HoldingsChannel reports. The fund purchased 7,119 shares of the company’s stock, valued at approximately $720,000.

Other large investors have also recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. increased its position in shares of Encompass Health by 3,059,159.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after purchasing an additional 3,793,358 shares during the last quarter. AlphaCore Capital LLC acquired a new stake in shares of Encompass Health in the 4th quarter valued at about $4,881,000. Systematic Financial Management LP lifted its position in shares of Encompass Health by 3.6% during the fourth quarter. Systematic Financial Management LP now owns 440,752 shares of the company’s stock worth $46,782,000 after purchasing an additional 15,462 shares during the last quarter. Asset Management One Co. Ltd. grew its stake in Encompass Health by 128.7% in the fourth quarter. Asset Management One Co. Ltd. now owns 129,205 shares of the company’s stock worth $13,790,000 after purchasing an additional 72,703 shares in the last quarter. Finally, Trillium Asset Management LLC grew its stake in Encompass Health by 5.7% in the fourth quarter. Trillium Asset Management LLC now owns 217,734 shares of the company’s stock worth $23,424,000 after purchasing an additional 11,793 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Stock Up 0.3%

NYSE:EHC opened at $122.35 on Wednesday. The firm has a market capitalization of $12.07 billion, a PE ratio of 19.93, a price-to-earnings-growth ratio of 2.51 and a beta of 0.72. The stock has a 50 day moving average of $109.89 and a 200-day moving average of $105.91. Encompass Health Corporation has a 52 week low of $92.77 and a 52 week high of $127.99. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.48 by $0.07. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter last year, the business posted $1.40 EPS. The business’s revenue was up 9.6% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Analysts predict that Encompass Health Corporation will post 6.08 EPS for the current year.

Encompass Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a $0.21 dividend. The ex-dividend date is Thursday, October 1st. This is a positive change from Encompass Health’s previous quarterly dividend of $0.19. This represents a $0.84 dividend on an annualized basis and a yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is 12.38%.

Wall Street Analyst Weigh In

EHC has been the topic of several research reports. Truist Financial upped their price objective on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Weiss Ratings upgraded Encompass Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 12th. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday. TD Cowen upped their price target on Encompass Health from $125.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, August 10th. Finally, UBS Group raised their price objective on Encompass Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $148.71.

Insiders Place Their Bets

In related news, EVP John Patrick Darby sold 8,906 shares of Encompass Health stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.95, for a total value of $1,121,710.70. Following the sale, the executive vice president directly owned 75,041 shares in the company, valued at $9,451,413.95. This trade represents a 10.61% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Mark J. Tarr sold 173,148 shares of the business’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the transaction, the chief executive officer directly owned 267,814 shares of the company’s stock, valued at $33,602,622.58. The trade was a 39.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 1.80% of the company’s stock.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.